Internal Medicine, Endocrinology, Diabetes, & Metabolism · Dallas, TX
NPI
1922283506
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3430 W Wheatland Rd, Pob I Ste#219
Dallas, TX, 75237
Phone (972) 298-7450
Groups this clinician bills Medicare through
Medicare paid, 2024
$131K
1,947 services
Medicare patients, 2024
269
Average age 72
Drug cost, 2024
$5.0M
5,697 prescriptions
Company payments, 2025
$300K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Saleemah Y Fahmi was code 99214 (office e&m - established), 834 times for 254 patients. In total Saleemah Y Fahmi billed 1,947 services in 14 codes, and Medicare paid $131K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-01-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 834 | 254 | $86.95 | $73K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 263 | 177 | $11.70 | $3,078 |
| 95251 Test - Miscellaneous | Office | 218 | 85 | $23.31 | $5,081 |
| 95923 Electrical Nerve Conductivity | Office | 148 | 128 | $88.71 | $13K |
| 93923 Duplex Scan - Extremity Arteries | Office | 137 | 121 | $93.36 | $13K |
| 95924 Electrical Nerve Conductivity | Office | 119 | 105 | $108.80 | $13K |
| 93040 Electrocardiogram | Office | 117 | 103 | $9.37 | $1,096 |
| 99215 Office E&M - Established | Office | 50 | 16 | $122.20 | $6,110 |
| 95249 Test - Miscellaneous | Office | 27 | 24 | $46.33 | $1,251 |
| 99204 Office E&M - New | Office | 20 | 20 | $123.02 | $2,460 |
By year: 2022 $152K for 2,236 services; 2023 $149K for 1,837 services; 2024 $131K for 1,947 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 43 | 42 | $3.60 | $155 |
Medicare prescription drug claims, 2024
In 2024, the drug Saleemah Y Fahmi prescribed most often to Medicare patients was Ozempic (Semaglutide), with 478 prescriptions and refills. In total Saleemah Y Fahmi wrote 5,697 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 478 | 651 | 108 | $612K |
| Mounjaro Tirzepatide | 459 | 550 | 82 | $573K |
| Jardiance Empagliflozin | 352 | 590 | 92 | $344K |
| Levothyroxine Sodium Generic | 295 | 717 | 89 | $3,367 |
| Trulicity Dulaglutide | 246 | 355 | 61 | $338K |
| Synthroid Levothyroxine Sodium | 243 | 493 | 64 | $20K |
| Tresiba Flextouch U-200 Insulin Degludec | 232 | 380 | 63 | $241K |
| Farxiga Dapagliflozin Propanediol | 232 | 384 | 53 | $204K |
| Metformin Hcl Generic | 173 | 398 | 46 | $2,800 |
| Methimazole Generic | 149 | 327 | 50 | $2,282 |
| Pioglitazone Hcl Generic | 143 | 384 | 40 | $1,265 |
| Metformin Hcl Er Metformin Hcl | 137 | 355 | 45 | $1,531 |
| Rosuvastatin Calcium Generic | 99 | 275 | 41 | $1,726 |
| Atorvastatin Calcium Generic | 93 | 258 | 31 | $1,045 |
| Amlodipine Besylate Generic | 79 | 211 | 27 | $521 |
Brand drugs: 3,458 claims; generic drugs: 1,993 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Saleemah Y Fahmi $300K ($300K in general payments such as food, travel and fees) from 26 companies. The largest payer was Amgen Inc. with $94K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 114 | $94K |
| Lilly USA, LLC LLY | 166 | $77K |
| Corcept Therapeutics CORT | 58 | $55K |
| Abbott Laboratories ABT | 82 | $44K |
| Xeris Pharmaceuticals, Inc. | 51 | $24K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $3,116 |
| Abbvie Inc. ABBV | 3 | $2,418 |
| Mannkind Corporation MNKD | 9 | $362 |
| Sequel Med Tech, LLC | 13 | $287 |
| Madrigal Pharmaceuticals MDGL | 6 | $169 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.